<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615040/" ref="ordinalpos=1967&amp;ncbi_uid=4782787&amp;link_uid=PMC3615040" image-link="/pmc/articles/PMC3615040/figure/pone-0060184-g002/" class="imagepopup">Figure 2. Intracellular mTOR, AKT, and AMPK <span class="highlight" style="background-color:">signaling</span> and induction of autophagy are impacted by cytotoxic ATP. A–B).  From: P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR <span class="highlight" style="background-color:">Signaling</span> Pathways to Mediate Tumor Cell Death. </a></div><br /><div class="p4l_captionBody">Western blot analysis of signaling components of mTOR (A), AKT and AMPK (B), in MCA38 cells after ATP treatment at different times as indicated. Inhibition of mTOR and AKT with concurrent stimulation of AMPK signaling was noted. <b>C–D)</b> Delineation of ATP-elicited intracellular signaling cascades by blockade of certain component using specific inhibitors, determined by Western blotting. OA (okadaic acid): 100 nM; LY294 (LY294002): 50 µM; RAPA (rapamycin): 100 nM; CC (compound C): 20 µM. <b>E)</b> Impacts of pathway inhibitors on autophagy in MCA38 cells, as examined by Western blots of LC3-II. β-actin is the loading control. Data represent three to six experiments.</div></div>